ZBH

Zimmer Biomet Holdings
D

ZBH

102.380
USD
0.58
(0.57%)
Market Closed
Volume
155,309
EPS
8
Div Yield
0.94
P/E
23
Market Cap
20,254,995,263
Related Instruments
ABT
ABT
1.930
(1.47%)
132.820 USD
BAX
BAX
0.020
(0.07%)
30.690 USD
BDX
BDX
-0.770
(-0.45%)
168.780 USD
COO
COO
2.303
(2.88%)
82.313 USD
EW
EW
0.480
(0.64%)
75.650 USD
ISRG
ISRG
12.25
(2.37%)
529.20 USD
JNJ
JNJ
1.720
(1.11%)
156.120 USD
MDT
MDT
1.280
(1.53%)
84.850 USD
SYK
SYK
4.11
(1.10%)
378.26 USD
More
News

Title: Zimmer Biomet Holdings

Sector: Healthcare
Industry: Medical Devices
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.